Links to other sites are provided as a convenience to the viewer.
Pfizer accepts no responsibility for the content of linked sites.
If cyanide poisoning is known or suspected, time may be running out.3
Comprehensive treatment of acute cyanide intoxication requires support of vital functions. Airway, ventilatory and circulatory support, oxygen administration, and management of seizures should not be delayed to administer CYANOKIT.3
CYANOKIT is indicated for the treatment of known or suspected cyanide poisoning.
|Key Product Specifications4:|
|Delivers||Full starting dose of 5 g of hydroxocobalamin in a single vial; diluent for infusion not included|
|Administration Type||Intravenous infusion|
|Dimensions||W: 194 mm x L: 100 mm x H: 97 mm|
|Packaged||1 kit per box|
|Kit Contains||One 250-mL glass vial containing 5 g lyophilized hydroxocobalamin for injection; one sterile transfer spike; one sterile intravenous infusion set; one package insert; one quick-use reference guide|
|Storage: Lyophilized Form||
Store at 25°C (77°F); excursions permitted to 15°C-30°C (59°F-86°F) [See USP Controlled Room Temperature].
CYANOKIT may be exposed, during short periods, to temperature variations of usual transport, transport in the desert, and freezing/defrosting cycles.
|Storage: Reconstituted Drug Product||
Once reconstituted, hydroxocobalamin is stable for up to 6 hours at temperatures not exceeding 40°C (104°F).
Do not freeze.
Any reconstituted product not used by 6 hours should be discarded.
Adverse Event or Product Quality Complaints
If you wish to report an adverse event or product quality complaint, please call 1-800-438-1985.
For medical questions concerning Meridian products, to report an adverse event, or to speak to a member of Pfizer US Medical Information, please call 1-800-438-1985.
CYANOKIT is a registered trademark of SERB Sarl, licensed by Meridian Medical Technologies, Inc., a Pfizer company.